Market Spotlight: Catheter Precision Inc (NYSE American: VTAK) Emerges as a Key Stock to Watch

This morning, many investors will be examining stocks that may have garnered significant attention on Monday, and among them, one stock worth monitoring could be Catheter Precision Inc (NYSE American: VTAK). 

Following a significant recent announcement from the company, the stock wrapped up the day with gains of 7.04%, reaching $0.61 per share. Trading at twice its average 30-day volume and closing higher than its 200-day moving average, the stock is entering breakout territory and displaying several bullish indicators. This makes it worth monitoring in the near term. 

The U.S.-based medical device firm gained attention in the news cycle yesterday following a significant announcement regarding its LockeT product. The company revealed that the product had been utilized for the first time outside the U.S. at the Heart Hospital of Hamad Medical Corporation in Doha, Qatar. 

It's worth mentioning that the Hamad Medical Corporation serves as Qatar's primary tertiary and secondary healthcare provider, standing as one of the leading hospital networks in the Middle East. Currently, HMC manages a total of 12 hospitals, comprising 9 specialty hospitals and the remaining 3 being community hospitals. 

Dr. Sajad Hayat discussed the LockeT product post-implementation, emphasizing the importance of ease of use and effectiveness in a vascular hemostasis product like LockeT. He affirmed that the product met both criteria. Additionally, Davin Jenkins, the Chief Executive Officer of Catheter Precision, also commented on this milestone. 

He observed that aside from the successful debut of the LockeT product beyond the borders of the United States, its value was swiftly acknowledged by the physician. He referenced Dr. Hayat's observations as a resounding endorsement of the product's effectiveness.


Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.